Literature DB >> 3261560

Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons.

M R Griffin1, W A Ray, W Schaffner.   

Abstract

STUDY
OBJECTIVE: To determine the association between current non-aspirin nonsteroidal anti-inflammatory drug (NSAID) use and fatal peptic ulcers or upper gastrointestinal hemorrhage.
DESIGN: Nested case control study using a linked Medicaid-death certificate database.
SETTING: Tennessee Medicaid enrollees aged 60 and greater from 1976 to 1984. PATIENTS: One hundred twenty-two patients, "the cases," had a terminal hospitalization and a peptic ulcer or upper gastrointestinal hemorrhage confirmed by hospital chart review. Population controls (n = 3897) were matched to potential cases by age, sex, race, calendar year, and nursing home status.
MEASUREMENTS AND MAIN RESULTS: "Cases" more frequently filled a prescription for an NSAID within 30 days before onset of illness than controls (34% compared with 11%; adjusted odds ratio, 4.7; 95% CI, 3.1 to 7.2). This association between fatal ulcer disease and current NSAID use was consistent in three age groups, women and men, whites and nonwhites, and community and nursing home dwellers. There was no significant association between case status and previous NSAID use (adjusted odds ratio, 1.9; 95% CI, 0.7 to 4.7).
CONCLUSIONS: The findings of this study add to the growing evidence that NSAIDs can increase the risk for clinically serious peptic ulcer disease in the elderly.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3261560     DOI: 10.7326/0003-4819-109-5-359

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  60 in total

1.  Pilot study for appropriate anti-infective community therapy. Effect of a guideline-based strategy to optimize use of antibiotics.

Authors:  J Stewart; J Pilla; L Dunn
Journal:  Can Fam Physician       Date:  2000-04       Impact factor: 3.275

Review 2.  Regular review: medical management of osteoarthritis.

Authors:  K Walker-Bone; K Javaid; N Arden; C Cooper
Journal:  BMJ       Date:  2000-10-14

3.  Placebo-controlled comparison of piroxicam-beta-cyclodextrin, piroxicam, and indomethacin on gastric potential difference and mucosal injury in humans.

Authors:  L Santucci; S Fiorucci; S Chiucchiù; A Sicilia; L Bufalino; A Morelli
Journal:  Dig Dis Sci       Date:  1992-12       Impact factor: 3.199

4.  Cost, benefits and unintended gastrointestinal side effects of pharmaceutical therapy.

Authors:  B S Bloom
Journal:  Pharmacoeconomics       Date:  1992-03       Impact factor: 4.981

Review 5.  NSAID gastropathy. The central issue.

Authors:  S H Roth
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 6.  Non-steroidal anti-inflammatory drugs and peptic ulcers.

Authors:  C J Hawkey
Journal:  BMJ       Date:  1990-02-03

Review 7.  Epidemiology of NSAID-induced gastropathy.

Authors:  H Zeidler
Journal:  Clin Rheumatol       Date:  1991-12       Impact factor: 2.980

8.  Changes in birth-cohort pattern of peptic ulcer mortality in England and Wales.

Authors:  B D Katschinski; R F Logan
Journal:  Postgrad Med J       Date:  1991-09       Impact factor: 2.401

9.  Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis.

Authors:  T Pincus; G Koch; H Lei; B Mangal; T Sokka; R Moskowitz; F Wolfe; A Gibofsky; L Simon; S Zlotnick; J G Fort
Journal:  Ann Rheum Dis       Date:  2004-04-13       Impact factor: 19.103

Review 10.  From peptic ulcer disease to NSAID gastropathy. An evolving nosology.

Authors:  S H Roth
Journal:  Drugs Aging       Date:  1995-05       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.